Viewing StudyNCT00034554



Ignite Creation Date: 2024-05-05 @ 11:25 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00034554
Status: COMPLETED
Last Update Posted: 2010-04-09
First Post: 2002-04-30

Brief Title: Study of gp75 Vaccine in Patients With Stage III and IV Melanoma
Sponsor: Eli Lilly and Company
Organization: Eli Lilly and Company

Conditions & Keywords Data

Conditions:
Name
Malignant Melanoma
Keywords:
Name View
DNA vaccine View
AJCC stage III or stage IV malignant melanoma View
melanoma View
gp75 View